Postgraduate Program in Epidemiology and Hospital de Clínicas, Universidade Federal do Rio Grande do Sul, Ramiro Barcelos, 2600/514, Porto Alegre, RS, 90035-003, Brazil.
Department of Neuroscience, Medical Research Center for Bioreaction to Reactive Oxygen Species and Biomedical Science Institute, School of Medicine, Graduate School, Kyung Hee University, Seoul, South Korea.
Environ Health. 2020 Oct 12;19(1):105. doi: 10.1186/s12940-020-00658-y.
Persistent organic pollutants (POPs) may cause diabetes, in part through aryl hydrocarbon receptor (AhR) binding. Ensuing mitochondrial dysfunction is postulated to mediate this effect. We aim to investigate the association of POPs with incident diabetes indirectly by bio-assaying AhR ligand bioactivity and intracellular ATP level induced by participant serum samples.
In incident case-cohort analyses of one ELSA-Brasil center, 1605 eligible subjects without diabetes at baseline had incident diabetes ascertained by self-report, medication use, OGTT or HbA1c at follow-up 4 years later. We assayed AhR ligand bioactivity (AhRL) and intracellular ATP content, the latter reflecting the presence of mitochondria-inhibiting substances (MIS), following incubation of recombinant mouse Hepa1c1c7 cells with participant sera for 71 incident diabetes cases and 472 randomly selected controls.
In multiply-adjusted proportional hazards regression analyses, those with above-median AhRL and below-median MIS-ATP had 69 and 226% greater risk of developing diabetes (HR = 1.69; 95%CI 1.01-2.83 and 3.26; 1.84-5.78), respectively. A strong interaction was seen between the two exposures (HR = 8.15; 2.86-23.2).
The markedly increased incidence of diabetes seen in those with both higher AhR ligand bioactivity and increased mitochondrial inhibition supports the hypothesis that widespread POPs exposure contributes to the diabetes epidemic.
持久性有机污染物 (POPs) 可能通过芳香烃受体 (AhR) 结合导致糖尿病。随后的线粒体功能障碍被认为介导了这种效应。我们旨在通过生物测定 AhR 配体生物活性和参与者血清样本诱导的细胞内 ATP 水平,间接研究 POPs 与新发糖尿病之间的关联。
在巴西 ELSA-Brasil 中心的一项新发病例对照分析中,1605 名基线时无糖尿病的合格受试者在 4 年后的随访中通过自我报告、用药情况、OGTT 或 HbA1c 确定新发糖尿病。我们测定了 AhR 配体生物活性 (AhRL) 和细胞内 ATP 含量,后者反映了存在抑制线粒体的物质 (MIS)。在重组小鼠 Hepa1c1c7 细胞孵育 71 例新发糖尿病病例和 472 例随机选择的对照者的血清后进行测定。
在多重调整后的比例风险回归分析中,AhRL 高于中位数且 MIS-ATP 低于中位数的人群发生糖尿病的风险分别增加了 69%和 226%(HR=1.69;95%CI 1.01-2.83 和 3.26;1.84-5.78)。两种暴露之间存在很强的交互作用(HR=8.15;2.86-23.2)。
在 AhR 配体生物活性较高且线粒体抑制增加的人群中,糖尿病的发病率显著增加,这支持了广泛的 POPs 暴露导致糖尿病流行的假设。